{"transactions":[{"id":1708657,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":3597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":7813,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":3597},"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708656,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":1632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023."}],"balance_after":7073,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":1632},"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708655,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020."}],"balance_after":7811,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":415},"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708654,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-15","kind":"gift","planned":false,"acquired":false,"shares":1785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,685 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":23348,"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708653,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":2407,"price":75.1,"value":180765.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."}],"balance_after":25133,"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708652,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":3597,"price":38.46,"value":138340.62,"ownership":{"direct":true},"balance_after":27540,"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708651,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":1509,"price":75.1,"value":113325.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."}],"balance_after":23943,"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708650,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":1632,"price":66.1,"value":107875.2,"ownership":{"direct":true},"balance_after":25452,"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708649,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":206,"price":75.1,"value":15470.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."}],"balance_after":23820,"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1708648,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-12-15T22:31:17.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":415,"price":16.14,"value":6698.1,"ownership":{"direct":true},"balance_after":24026,"source":{"system":"sec-edgar","filing":"0000950170-23-070835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023070835/ownership.xml","form_type":"4"}},{"id":1788688,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-05T20:36:40.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":false,"shares":3695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":11410,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":3695},"source":{"system":"sec-edgar","filing":"0000950170-23-046432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023046432/ownership.xml","form_type":"4"}},{"id":1788687,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-05T20:36:40.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":false,"shares":1785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":16496,"derivative":{"exercise_price":3.22,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0000950170-23-046432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023046432/ownership.xml","form_type":"4"}},{"id":1788686,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-09-05T20:36:40.000Z","date":"2023-08-31","kind":"sale","planned":false,"acquired":false,"shares":2708,"price":66.52,"value":180136.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $66.40 to $66.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,685 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":23611,"source":{"system":"sec-edgar","filing":"0000950170-23-046432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023046432/ownership.xml","form_type":"4"}},{"id":1788685,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-09-05T20:36:40.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":true,"shares":3695,"price":38.46,"value":142109.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."}],"balance_after":26319,"source":{"system":"sec-edgar","filing":"0000950170-23-046432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023046432/ownership.xml","form_type":"4"}},{"id":1788684,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-09-05T20:36:40.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":true,"shares":1785,"price":3.22,"value":5747.7,"ownership":{"direct":true},"balance_after":22624,"source":{"system":"sec-edgar","filing":"0000950170-23-046432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023046432/ownership.xml","form_type":"4"}},{"id":1998438,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-23T01:01:20.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":8705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service."}],"balance_after":8705,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":8705},"source":{"system":"sec-edgar","filing":"0000899243-23-005899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323005899/doc4.xml","form_type":"4"}},{"id":1998437,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2023-02-23T01:01:20.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":5685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 5,685 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":20839,"source":{"system":"sec-edgar","filing":"0000899243-23-005899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323005899/doc4.xml","form_type":"4"}},{"id":2084746,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-15T21:30:21.000Z","date":"2022-12-13","kind":"exercise","acquired":false,"shares":5918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":15105,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":5918},"source":{"system":"sec-edgar","filing":"0000899243-22-038601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038601/doc4.xml","form_type":"4"}},{"id":2084745,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2022-12-15T21:30:21.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":1620,"price":63,"value":102060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.72 to $63.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":15154,"source":{"system":"sec-edgar","filing":"0000899243-22-038601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038601/doc4.xml","form_type":"4"}},{"id":2084744,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2022-12-15T21:30:21.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":2695,"price":62.24,"value":167736.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.70 to $62.69, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":16774,"source":{"system":"sec-edgar","filing":"0000899243-22-038601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038601/doc4.xml","form_type":"4"}},{"id":2084743,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2022-12-15T21:30:21.000Z","date":"2022-12-13","kind":"exercise","acquired":true,"shares":5918,"price":38.46,"value":227606.28,"ownership":{"direct":true},"balance_after":19469,"source":{"system":"sec-edgar","filing":"0000899243-22-038601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038601/doc4.xml","form_type":"4"}},{"id":2087407,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-13T21:30:28.000Z","date":"2022-12-09","kind":"exercise","acquired":false,"shares":1149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020."}],"balance_after":8226,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":1149},"source":{"system":"sec-edgar","filing":"0000899243-22-038318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038318/doc4.xml","form_type":"4"}},{"id":2087406,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-13T21:30:28.000Z","date":"2022-12-09","kind":"exercise","acquired":false,"shares":3977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":21023,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":3977},"source":{"system":"sec-edgar","filing":"0000899243-22-038318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038318/doc4.xml","form_type":"4"}},{"id":2087405,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-13T21:30:28.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":18281,"derivative":{"exercise_price":3.22,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0000899243-22-038318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038318/doc4.xml","form_type":"4"}},{"id":2087404,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2022-12-13T21:30:28.000Z","date":"2022-12-09","kind":"sale","acquired":false,"shares":567,"price":59,"value":33453.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."}],"balance_after":13551,"source":{"system":"sec-edgar","filing":"0000899243-22-038318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038318/doc4.xml","form_type":"4"}},{"id":2087403,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2022-12-13T21:30:28.000Z","date":"2022-12-09","kind":"exercise","acquired":true,"shares":1149,"price":16.14,"value":18544.86,"ownership":{"direct":true},"balance_after":14118,"source":{"system":"sec-edgar","filing":"0000899243-22-038318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038318/doc4.xml","form_type":"4"}},{"id":2087402,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2022-12-13T21:30:28.000Z","date":"2022-12-09","kind":"sale","acquired":false,"shares":3046,"price":59,"value":179714.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."}],"balance_after":12969,"source":{"system":"sec-edgar","filing":"0000899243-22-038318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038318/doc4.xml","form_type":"4"}},{"id":2087401,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2022-12-13T21:30:28.000Z","date":"2022-12-09","kind":"exercise","acquired":true,"shares":3977,"price":38.46,"value":152955.42,"ownership":{"direct":true},"balance_after":16015,"source":{"system":"sec-edgar","filing":"0000899243-22-038318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038318/doc4.xml","form_type":"4"}},{"id":2087400,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Global Regulatory Affairs"}}],"security":"Common Stock","published_at":"2022-12-13T21:30:28.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":2600,"price":3.22,"value":8372.0,"ownership":{"direct":true},"balance_after":12038,"source":{"system":"sec-edgar","filing":"0000899243-22-038318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038318/doc4.xml","form_type":"4"}},{"id":2373907,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Global Regl. Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-24T22:47:47.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":38000,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common\nStock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0000899243-22-007680","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322007680/doc4.xml","form_type":"4"}},{"id":2457672,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-28T21:30:28.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date."}],"balance_after":20881,"derivative":{"exercise_price":3.22,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":884},"source":{"system":"sec-edgar","filing":"0000899243-21-049930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321049930/doc4.xml","form_type":"4"}},{"id":2457671,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Common Stock","published_at":"2021-12-28T21:30:28.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":884,"price":3.22,"value":2846.48,"ownership":{"direct":true},"balance_after":9438,"source":{"system":"sec-edgar","filing":"0000899243-21-049930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321049930/doc4.xml","form_type":"4"}},{"id":2564696,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-17T20:34:16.000Z","date":"2021-09-15","kind":"exercise","acquired":false,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020."}],"balance_after":9375,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0000899243-21-036415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321036415/doc4.xml","form_type":"4"}},{"id":2564695,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Common Stock","published_at":"2021-09-17T20:34:16.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":3877,"price":31.34,"value":121505.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options."}],"balance_after":8554,"source":{"system":"sec-edgar","filing":"0000899243-21-036415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321036415/doc4.xml","form_type":"4"}},{"id":2564694,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Common Stock","published_at":"2021-09-17T20:34:16.000Z","date":"2021-09-15","kind":"exercise","acquired":true,"shares":5625,"price":16.14,"value":90787.5,"ownership":{"direct":true},"balance_after":12431,"source":{"system":"sec-edgar","filing":"0000899243-21-036415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321036415/doc4.xml","form_type":"4"}},{"id":2616644,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-03T21:00:35.000Z","date":"2021-07-30","kind":"exercise","acquired":false,"shares":2206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date."}],"balance_after":21765,"derivative":{"exercise_price":3.22,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":2206},"source":{"system":"sec-edgar","filing":"0000899243-21-031299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321031299/doc4.xml","form_type":"4"}},{"id":2616643,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Common Stock","published_at":"2021-08-03T21:00:35.000Z","date":"2021-07-30","kind":"exercise","acquired":true,"shares":2206,"price":3.22,"value":7103.32,"ownership":{"direct":true},"balance_after":6806,"source":{"system":"sec-edgar","filing":"0000899243-21-031299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321031299/doc4.xml","form_type":"4"}},{"id":2828867,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-26T22:45:16.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":25000,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-008444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321008444/doc4.xml","form_type":"4"}},{"id":2945852,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-14T21:53:15.000Z","date":"2020-12-11","kind":"exercise","acquired":false,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and will vest at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date."}],"balance_after":23971,"derivative":{"exercise_price":3.22,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0000899243-20-033750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320033750/doc4.xml","form_type":"4"}},{"id":2945851,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Common Stock","published_at":"2020-12-14T21:53:15.000Z","date":"2020-12-11","kind":"exercise","acquired":true,"shares":4600,"price":3.22,"value":14812.0,"ownership":{"direct":true},"balance_after":4600,"source":{"system":"sec-edgar","filing":"0000899243-20-033750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320033750/doc4.xml","form_type":"4"}},{"id":3221991,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T23:11:26.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020."}],"balance_after":15000,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-007511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320007511/doc4.xml","form_type":"4"}},{"id":3537597,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:46:54.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":28571,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public\noffering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger\nAgreement\"), each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the\nIssuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public\noffering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger\nAgreement\"), each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the\nIssuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public\noffering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger\nAgreement\"), each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the\nIssuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public\noffering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger\nAgreement\"), each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the\nIssuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and at a rate of 2.0833% each month thereafter until the option is fully vested\non the fourth anniversary of the vesting date."}],"balance_after":28571,"derivative":{"exercise_price":3.22,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0000899243-19-012300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012300/doc4.xml","form_type":"4"}},{"id":3537596,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":96120,"kind":"person","name":"Provost Miriam","position":1,"cik":"0001773663","reported_name":"Provost Miriam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of US Regulatory & FDA Rel."}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:46:54.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public\noffering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger\nAgreement\"), each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the\nIssuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public\noffering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger\nAgreement\"), each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the\nIssuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public\noffering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger\nAgreement\"), each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the\nIssuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and at a rate of 2.0833% each month thereafter until the option is fully vested\non the fourth anniversary of the vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.92,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0000899243-19-012300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012300/doc4.xml","form_type":"4"}}]}